Vanguard Health Care Fund Buys Regeneron Pharmaceuticals Inc, Edwards Lifesciences Corp, Danaher Corp, Sells Eli Lilly and Co, Vertex Pharmaceuticals Inc, Chugai Pharmaceutical Co

• New Purchases: SYK, RPRX, 02269,
• Added Positions: REGN, EW, DHR, PFE, TMO, A, BSX, BIIB, ISRG, TFX, 4568, NVST, 4503, 4543, HOLX, BLUE, MYL,
• Reduced Positions: LLY, VRTX, 4519, MRK, MDT, ZBH, SGEN, BMY, ELAN, MOH, UCB, CNC, ALNY, ROG, 6869, 4502, ILMN, ARGX,
• Sold Out: QGEN, PTLA, CTEC,

For the details of Vanguard Health Care Fund's stock buys and sells, go to https://www.gurufocus.com/guru/vanguard+health+care+fund/current-portfolio/portfolio

1. UnitedHealth Group Inc (UNH) - 9,095,277 shares, 5.82% of the total portfolio.
2. AstraZeneca PLC (AZN) - 24,437,364 shares, 5.52% of the total portfolio.
3. Pfizer Inc (PFE) - 72,260,247 shares, 5.13% of the total portfolio. Shares added by 12.70%
4. Bristol-Myers Squibb Company (BMY) - 35,181,964 shares, 4.49% of the total portfolio. Shares reduced by 5.22%
5. Novartis AG (NOVN) - 19,912,128 shares, 3.76% of the total portfolio.

Vanguard Health Care Fund initiated holding in Stryker Corp. The purchase prices were between $144.67 and $207.03, with an estimated average price of $184.16. The stock is now traded at around $200.55. The impact to a portfolio due to this purchase was 0.42%. The holding were 1,079,241 shares as of .

Vanguard Health Care Fund initiated holding in Royalty Pharma PLC. The purchase prices were between $44.5 and $52.11, with an estimated average price of $49.5. The stock is now traded at around $42.78. The impact to a portfolio due to this purchase was 0.32%. The holding were 3,053,455 shares as of .

Vanguard Health Care Fund initiated holding in WuXi Biologics (Cayman) Inc. The purchase prices were between $100.5 and $149.5, with an estimated average price of $125.63. The stock is now traded at around $159.50. The impact to a portfolio due to this purchase was 0.25%. The holding were 6,344,000 shares as of .

Vanguard Health Care Fund added to a holding in Regeneron Pharmaceuticals Inc by 42.78%. The purchase prices were between $488.29 and $643.92, with an estimated average price of $565.62. The stock is now traded at around $631.47. The impact to a portfolio due to this purchase was 1.04%. The holding were 2,556,310 shares as of .

Vanguard Health Care Fund added to a holding in Edwards Lifesciences Corp by 235.29%. The purchase prices were between $57.54 and $76.95, with an estimated average price of $70.98. The stock is now traded at around $78.95. The impact to a portfolio due to this purchase was 0.99%. The holding were 9,400,502 shares as of .

Vanguard Health Care Fund added to a holding in Danaher Corp by 71.39%. The purchase prices were between $128.7 and $176.83, with an estimated average price of $161.23. The stock is now traded at around $202.10. The impact to a portfolio due to this purchase was 0.9%. The holding were 5,640,599 shares as of .

Vanguard Health Care Fund added to a holding in Thermo Fisher Scientific Inc by 26.26%. The purchase prices were between $275.2 and $362.34, with an estimated average price of $334.21. The stock is now traded at around $410.56. The impact to a portfolio due to this purchase was 0.55%. The holding were 3,347,387 shares as of .

Vanguard Health Care Fund added to a holding in Agilent Technologies Inc by 245.37%. The purchase prices were between $68.92 and $91.14, with an estimated average price of $81.76. The stock is now traded at around $95.94. The impact to a portfolio due to this purchase was 0.41%. The holding were 3,049,141 shares as of .

Vanguard Health Care Fund added to a holding in Intuitive Surgical Inc by 257.31%. The purchase prices were between $458.26 and $592.76, with an estimated average price of $536.99. The stock is now traded at around $687.39. The impact to a portfolio due to this purchase was 0.26%. The holding were 291,269 shares as of .

Vanguard Health Care Fund sold out a holding in Qiagen NV. The sale prices were between $39.49 and $44.36, with an estimated average price of $42.17.

Vanguard Health Care Fund sold out a holding in Portola Pharmaceuticals Inc. The sale prices were between $6.41 and $17.99, with an estimated average price of $13.76.

Vanguard Health Care Fund sold out a holding in ConvaTec Group PLC. The sale prices were between $1.78 and $2.19, with an estimated average price of $1.99.

Vanguard Health Care Fund reduced to a holding in Eli Lilly and Co by 22.16%. The sale prices were between $136.42 and $164.18, with an estimated average price of $153.12. The stock is now traded at around $153.00. The impact to a portfolio due to this sale was -1.05%. Vanguard Health Care Fund still held 10,526,547 shares as of .

Vanguard Health Care Fund reduced to a holding in Vertex Pharmaceuticals Inc by 27.52%. The sale prices were between $225.48 and $295.8, with an estimated average price of $270.45. The stock is now traded at around $279.40. The impact to a portfolio due to this sale was -0.76%. Vanguard Health Care Fund still held 3,342,220 shares as of .

Vanguard Health Care Fund reduced to a holding in Chugai Pharmaceutical Co Ltd by 25.65%. The sale prices were between $4025 and $5821.67, with an estimated average price of $4818.65. The stock is now traded at around $4968.00. The impact to a portfolio due to this sale was -0.67%. Vanguard Health Care Fund still held 20,021,400 shares as of .

Vanguard Health Care Fund reduced to a holding in Merck & Co Inc by 34.54%. The sale prices were between $73.8 and $83.98, with an estimated average price of $78.88. The stock is now traded at around $79.07. The impact to a portfolio due to this sale was -0.59%. Vanguard Health Care Fund still held 5,732,246 shares as of .

Vanguard Health Care Fund reduced to a holding in Zimmer Biomet Holdings Inc by 66.1%. The sale prices were between $89.63 and $137.4, with an estimated average price of $118.39. The stock is now traded at around $138.24. The impact to a portfolio due to this sale was -0.42%. Vanguard Health Care Fund still held 836,580 shares as of .

Vanguard Health Care Fund reduced to a holding in Seattle Genetics Inc by 41.3%. The sale prices were between $111.24 and $171.13, with an estimated average price of $148.32. The stock is now traded at around $171.14. The impact to a portfolio due to this sale was -0.34%. Vanguard Health Care Fund still held 1,669,723 shares as of .